InsidersTradesSigma
Track the BIO share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the authority of ASX. Market capitalisation: €61.6m. The latest transaction was reported on 25 June 2026 (Purchase). Among the most active insiders: Blair Vega Norfolk. All data is openly available.
Analysts rate BIO Strong Buy (bullish), based on 1 analysts. Average price target: A$0.75.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
BIO is a company listed on the XASX market, specializing in the biotechnology sector. It focuses on developing innovative health solutions.